Drug Profile
LP 08
Alternative Names: LP-08Latest Information Update: 19 Feb 2022
Price :
$50
*
At a glance
- Originator Lipella Pharmaceuticals
- Class Phospholipids; Sphingolipids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Interstitial cystitis
Most Recent Events
- 19 Feb 2022 Discontinued - Phase-II for Interstitial cystitis in USA (Intravesicular)